FIELD: medicine, immunology. SUBSTANCE: one should carry out the following stages (a) and (b), moreover, (a) is the stage of leukocytic destruction in blood sample with the following aqueous liquids (i) and (ii) or the mixture of these aqueous liquids (i) and (ii), where (i) is aqueous liquid at osmotic pressure of 250 mOsm/kg H2O or lower or aqueous liquid at osmotic pressure of 310 mOsm/kg H2O or higher; (ii) is aqueous liquid including hemolysate; and stage (b) deals with immunological detection of human medullazine quantity released into mentioned blood sample out of leukocytes destroyed at stage (a), with the help of antibody against human medullazine. EFFECT: higher accuracy of diagnostics. 18 cl, 4 dwg, 4 ex, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
NOVEL ANTIBODY, COMPOUND WITH RENIN ACTIVITY COMPRISING NOVEL ANTIBODY AND METHOD OF PRORENIN ASSAY USING NOVEL ANTIBODY | 1998 |
|
RU2198894C2 |
ANALYSIS OF MYCOBACTERIUM TUBERCULOSIS COMPLEX IMMUNODETECTION | 2008 |
|
RU2473095C2 |
FUSED PARTNER CELL | 2007 |
|
RU2431667C9 |
SPECIFICALLY PURIFIED ANTIBODIES AGAINST PRESEPSIN | 2015 |
|
RU2739607C2 |
METHOD FOR MEASURING HUMAN MEGALINE | 2007 |
|
RU2463608C2 |
COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISEASES | 2010 |
|
RU2569109C2 |
ANTIBODY AGAINST OSTEOPONTIN AND ITS USING | 2002 |
|
RU2299888C2 |
METHOD FOR IMMUNOENZYMOMETRIC ANALYSIS OF IDIOTYPIC AND ANTI-IDIOTYPIC ANTIBODIES TO BENZO[A]PYRENE IN HUMAN BIOLOGICAL FLUIDS | 2019 |
|
RU2741382C1 |
IL-17A LINKING AGENT AND METHODS FOR USE THEREOF | 2014 |
|
RU2682046C1 |
METHOD FOR DETERMINATION OF MEMBERS OF FAMILY OF S100 CALCIUM-BINDING PROTEINS BY MEANS OF IMMUNOTURBIDIMETRY | 2018 |
|
RU2780565C2 |
Authors
Dates
2003-08-10—Published
2000-11-14—Filed